Embedded Files
Clinical Reports & Newsletters
Clinical Reports & Newsletters
Medical Conference & Literature Coverage
Medical Conference & Literature Coverage
Reports on seminal data from national and international medical conferences, and summaries of clinical evidence from medical publications
Evolocumab Improves CV Risk As Statin Add.pdfEvolocumab Improves CV Risk
As Statin Add-On in FOURIER
ODYSSEY alirocumab safety diabetes.pdfAlirocumab Safe in People With Diabetes Across ODYSSEY Trials
CTTC Lower LDL Safe.pdfLDL-C Lowering Beyond Current Targets Safe, Reduces CV Risk
EMPA-REG OUTCOME Coverage.pdfEmpagliflozin Cuts CV Deaths in Landmark EMPA-REG OUTCOME
EMPA-REG OUTCOME Renal Coverage.pdfEmpagliflozin Slows Nephropathy
in Diabetes: EMPA-REG OUTCOME
IRIS Coverage.pdfPioglitazone Reduces Type 2 Diabetes by Half in IRIS
Clinical Newsletters
Clinical Newsletters
Clinical evidence reports in newsletter form (digital and/or print)
OnsiteInsight ACC14 DC.pdfOnsiteInsight: ACC Coverage
from Washington, DC
OnsiteInsight AHA12 LA.pdfOnsiteInsight: AHA Coverage
from Los Angeles, CA
Clinical Insights in Diabetes Vol 14 Issue 3.pdfClinical Insights in Diabetes:
DPP-4 CV Safety Studies
Clinical Insights in Diabetes Vol 14 Issue 2.pdfClinical Insights in Diabetes:
ORIGIN-GRACE and diabetes news
Clinical Insights in Diabetes Vol 14 Issue 1.pdfClinical Insights in Diabetes:
Mediterranean Diet, CVD Prevention
Get in touch at danielle.gabriel33@gmail.com
Get in touch at danielle.gabriel33@gmail.com
Page updated
Google Sites
Report abuse